Preventing renal failure in patients with severe lupus nephritis
- 1 April 2005
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 67 (94) , S116-S119
- https://doi.org/10.1111/j.1523-1755.2005.09427.x
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Combination Therapy with Pulse Cyclophosphamide plus Pulse Methylprednisolone Improves Long-Term Renal Outcome without Adding Toxicity in Patients with Lupus NephritisAnnals of Internal Medicine, 2001
- Factors predictive of outcome in severe lupus nephritisAmerican Journal of Kidney Diseases, 2000
- The very long-term prognosis and complications of lupus nephritis and its treatmentQJM: An International Journal of Medicine, 1999
- Methylprednisolone and Cyclophosphamide, Alone or in Combination, in Patients with Lupus NephritisAnnals of Internal Medicine, 1996
- Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritisThe Lancet, 1992
- Progression and Remission of Renal Disease in the Lupus Nephritis Collaborative StudyAnnals of Internal Medicine, 1992
- Long‐term preservation of renal function in patients with lupus nephritis receiving treatment that includes cyclophosphamide versus those treated with prednisone onlyArthritis & Rheumatism, 1991
- Therapy of Lupus NephritisNew England Journal of Medicine, 1986
- Treatment of Diffuse Proliferative Lupus Nephritis with Prednisone and Combined Prednisone and CyclophosphamideNew England Journal of Medicine, 1978
- Long‐Term Prognosis of Systemic Lupus ErythematosusActa Medica Scandinavica, 1966